EXENATIDE Side Effects

7007097-3 | Pancreatitis
on Sep 09, 2010 Female patient from FRANCE , weighting 122.1 lb, was diagnosed with diabetes mellitus, hypertension, hypercholesterolaemia and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Exenatide dosage: 10 Ug, 2/d. During the same period patient was treated with GLIMEPIRIDE (2 Mg, Unk) (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (Unk, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), KORETIC (20 Mg, Unk) (View Koretic Review and Koretic Label ), TAHOR (10, Unk) (View Tahor Review and Tahor Label ).

7005833-3 | Diarrhoea, Headache, Hyperhidrosis, Hypoglycaemia, Malaise, Tachycardia, Vomiting
Patient was taking Exenatide (View Usage). Patient had the following side effects: diarrhoea, headache (What is headache?), hyperhidrosis, hypoglycaemia, malaise, tachycardia, vomiting on Sep 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 49 years of age, weighting 189.6 lb, . Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with GLICLAZIDE (160 Mg, 2/d) (View Gliclazide Review and Gliclazide Label ), METFORMIN (1 G, 2/d) (View Metformin Review and Metformin Label ). Patient was hospitalized.

7005827-8 | Blood Glucose Increased, Incorrect Dose Administered, Injection Site Erythema
Adverse event was reported on Sep 16, 2010 by a Female patient taking Exenatide (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 271.2 lb, After Exenatide was administered, patient had the following side effects: blood glucose increased, incorrect dose administered, injection site erythema.

6983882-9 | Meningioma
on Sep 03, 2010 Female patient from UNITED STATES , weighting 393.1 lb, was diagnosed with diabetes mellitus, depression (What is depression?), headache (What is headache?), polycystic ovaries, hypertension and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: meningioma. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with ABILIFY (15 Mg, Daily (1/d)) (View Abilify Review and Abilify Label ), LEXAPRO (20 Mg, Daily (1/d)) (View Lexapro Review and Lexapro Label ), LAMICTAL (25 Mg, Daily (1/d)) (View Lamictal Review and Lamictal Label ), TOPAMAX (25 Mg, Unk) (View Topamax Review and Topamax Label ), MEDROXYPROGESTERONE (10 Mg, Daily (1/d)) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), MONOPRIL (10 Mg, Daily (1/d)) (View Monopril Review and Monopril Label ), METFORMIN HCL (1 G, 2/d) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.


6976645-1 | Blood Magnesium Abnormal, Chest Pain, Dehydration
on Aug 27, 2010 Female patient from UNITED STATES , weighting 271.8 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). Patient had the following side effects: blood magnesium abnormal, chest pain (What is chest pain?), dehydration. Exenatide dosage: 10 Mg, 2/d. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ). Patient was hospitalized.

6942516-X | Hepatic Neoplasm Malignant, Off Label Use
Patient was taking Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: hepatic neoplasm malignant, off label use on Aug 18, 2010 from COSTA RICA Additional patient health information: Male patient , 46 years of age, was diagnosed with diabetes mellitus and. Exenatide dosage: 5 Ug, 2/d. Patient was hospitalized.

6926412-X | Pancreatitis
Adverse event was reported on Aug 16, 2010 by a Male patient taking Exenatide (View Usage) (Dosage: 10 Mcg Bid Sq) was diagnosed with diabetes mellitus, hypertension and. Location: UNITED STATES , 61 years of age, weighting 266.8 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg Every Day Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6923922-6 | Blood Glucose Increased, Incorrect Dose Administered
on Aug 05, 2010 Female patient from UNITED KINGDOM , 55 years of age, was treated with Exenatide (View Usage). Patient had the following side effects: blood glucose increased, incorrect dose administered. Exenatide dosage: .

6830617-6 | Thyroid Cancer
on Jul 01, 2010 Female patient from JAPAN , 64 years of age, weighting 135.6 lb, was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertension and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: thyroid cancer (What is thyroid cancer?). Exenatide dosage: 5 Ug, Unk. During the same period patient was treated with EXENATIDE LONG ACTING RELEASE 2MG (2 Mg, Unk) (View Exenatide Long Acting Release 2mg Review and Exenatide Long Acting Release 2mg Label ), AMARYL (2 Mg, Daily (1/d)) (View Amaryl Review and Amaryl Label ), NELBIS (250 Mg, 2/d) (View Nelbis Review and Nelbis Label ), LIPITOR (10 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ), ARTIST (10 Mg, Daily (1/d)) (View Artist Review and Artist Label ).

6822116-2 | Lipase Increased
Patient was taking Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: lipase increased on Jun 24, 2010 from FRANCE Additional patient health information: Female patient , weighting 122.1 lb, was diagnosed with diabetes mellitus, hypertension, hypercholesterolaemia and. Exenatide dosage: 10 Ug, 2/d. During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (Unk, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), NEBILOX (View Nebilox Review and Nebilox Label ), KORETIC (20 Mg, Unk) (View Koretic Review and Koretic Label ), TAHOR (10, Unk) (View Tahor Review and Tahor Label ).

6768419-1 | Blood Creatinine Abnormal, Renal Failure
Adverse event was reported on Jun 02, 2010 by a Female patient taking Exenatide (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: SPAIN , 58 years of age, Patient had the following side effects: blood creatinine abnormal, renal failure. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), ACE INHIBITORS AND DIURETICS (View Ace Inhibitors And Diuretics Review and Ace Inhibitors And Diuretics Label ).

6765943-2 | Thyroid Cancer
on May 28, 2010 Female patient from JAPAN , 64 years of age, weighting 135.6 lb, was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertension and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: thyroid cancer (What is thyroid cancer?). Exenatide dosage: 5 Ug, Unk. During the same period patient was treated with EXENATIDE LONG ACTING RELEASE 2MG (2 Mg, Unk) (View Exenatide Long Acting Release 2mg Review and Exenatide Long Acting Release 2mg Label ), AMARYL (2 Mg, Daily (1/d)) (View Amaryl Review and Amaryl Label ), NELBIS (250 Mg, 2/d) (View Nelbis Review and Nelbis Label ), LIPITOR (10 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ), ARTIST (10 Mg, Daily (1/d)) (View Artist Review and Artist Label ).

6757555-1 | Calculus Urinary, Pyelonephritis
on May 26, 2010 Female patient from SPAIN , weighting 183.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, dyslipidaemia and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: calculus urinary, pyelonephritis. Exenatide dosage: 10 Ug, 2/d. During the same period patient was treated with INSULIN GLARGINE (46 U, Each Evening) (View Insulin Glargine Review and Insulin Glargine Label ), METFORMIN (2550 Mg, Daily (1/d)) (View Metformin Review and Metformin Label ), IRBESARTAN (75 Mg, Unk) (View Irbesartan Review and Irbesartan Label ), FENOFIBRAT (160 Mg, Unk) (View Fenofibrat Review and Fenofibrat Label ), EZETIMIBE (10 Mg, Unk) (View Ezetimibe Review and Ezetimibe Label ). Patient was hospitalized.

6748880-9 | Diarrhoea, Headache, Hyperhidrosis, Hypoglycaemia, Malaise, Tachycardia, Vomiting
Patient was taking Exenatide (View Usage). Patient had the following side effects: diarrhoea, headache (What is headache?), hyperhidrosis, hypoglycaemia, malaise, tachycardia, vomiting on May 20, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 49 years of age, weighting 189.6 lb, . Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with GLICLAZIDE (160 Mg, 2/d) (View Gliclazide Review and Gliclazide Label ), METFORMIN HCL (1 G, 2/d) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6741190-5 | Thyroid Cancer
Adverse event was reported on May 17, 2010 by a Female patient taking Exenatide (View Usage) (Dosage: 5 Ug, Unk) was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertension and. Location: JAPAN , 64 years of age, weighting 135.6 lb, After Exenatide was administered, patient had the following side effects: thyroid cancer (What is thyroid cancer?). During the same period patient was treated with EXENATIDE LONG ACTING RELEASE 2MG (2 Mg, Unk) (View Exenatide Long Acting Release 2mg Review and Exenatide Long Acting Release 2mg Label ), AMARYL (2 Mg, Daily (1/d)) (View Amaryl Review and Amaryl Label ), NELBIS (250 Mg, 2/d) (View Nelbis Review and Nelbis Label ), LIPITOR (10 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ), ARTIST (10 Mg, Daily (1/d)) (View Artist Review and Artist Label ).

6727233-3 | Cerebral Infarction, Fall, Lacunar Infarction, Off Label Use
on May 03, 2010 Male patient from DENMARK , weighting 202.8 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, fall (What is fall?), lacunar infarction, off label use. Exenatide dosage: 5 Ug, Daily (1/d). During the same period patient was treated with IRBESARTAN (300 Mg, Daily (1/d)) (View Irbesartan Review and Irbesartan Label ), ACTRAPID /00030501/ (45 Iu, 3/d) (View Actrapid /00030501/ Review and Actrapid /00030501/ Label ), INSULATARD (60 Iu, Daily (1/d)) (View Insulatard Review and Insulatard Label ).

6663073-1 | Abdominal Pain Upper, Blood Glucose Increased, Fall, Knee Operation, Musculoskeletal Stiffness, Nausea
on Mar 29, 2010 Female patient from UNITED STATES , weighting 245.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). Patient had the following side effects: abdominal pain upper, blood glucose increased, fall (What is fall?), knee operation, musculoskeletal stiffness, nausea (What is nausea?). Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with LIPITOR (40 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ), ACTOS (Unk, Unk) (View Actos Review and Actos Label ), METFORMIN (GLUCOPHAGE) (1000 Mg, 2/d) (View Metformin (glucophage) Review and Metformin (glucophage) Label ), ACCUPRIL (10 Mg, Daily (1/d)) (View Accupril Review and Accupril Label ), ASPIRIN (81 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), FERROUS SULFATE TAB (67 Mg, Daily (1/d)) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), TRIAMINICIN /00384601/ (Unk, Daily (1/d)) (View Triaminicin /00384601/ Review and Triaminicin /00384601/ Label ).

6656272-6 | Thyroid Cancer
Patient was taking Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: thyroid cancer (What is thyroid cancer?) on Mar 26, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 211.4 lb, . Exenatide dosage: . During the same period patient was treated with SITAGLIPTIN/MEFORMIN (View Sitagliptin/meformin Review and Sitagliptin/meformin Label ), INSULIN GLULISINE (View Insulin Glulisine Review and Insulin Glulisine Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIZIDE (View Olmesartan Medoxomil And Hydrochlorothizide Review and Olmesartan Medoxomil And Hydrochlorothizide Label ).

6626207-0 | Ischaemic Cardiomyopathy
Adverse event was reported on Feb 24, 2010 by a Male patient taking Exenatide (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypertension, hyperlipidaemia and. Location: UNITED STATES , weighting 234.0 lb, Patient experienced the following unwanted or unexpected effects: ischaemic cardiomyopathy. During the same period patient was treated with LOTREL (Unk, Unk) (View Lotrel Review and Lotrel Label ), JANUMET (View Janumet Review and Janumet Label ), SELENIUM (View Selenium Review and Selenium Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6616683-1 | Myocardial Ischaemia
on Mar 02, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). Patient had the following side effects: myocardial ischaemia. Exenatide dosage: 2.0 Mg, Weekly (1/w). During the same period patient was treated with GLYCORAN (500 Mg, Daily (1/d)) (View Glycoran Review and Glycoran Label ), ACTOS (15 Mg, Daily (1/d)) (View Actos Review and Actos Label ), XALATAN (Unk, Daily (1/d)) (View Xalatan Review and Xalatan Label ), CARTEOLOL HYDROCHLORIDE (Unk, Daily (1/d)) (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ), HYALURONATE SODIUM (Unk, 4/d) (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ).

6613850-8 | Faeces Discoloured
on Feb 24, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: faeces discoloured. Exenatide dosage: 2 Mg, Weekly (1/w). During the same period patient was treated with GLIMICRON (40 Mg, Daily (1/d)) (View Glimicron Review and Glimicron Label ), MELBIN (750 Mg, Unk) (View Melbin Review and Melbin Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ), LIPITOR (10 Mg, Unk) (View Lipitor Review and Lipitor Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6613670-4 | Cerebral Infarction, Lacunar Infarction, Off Label Use
Patient was taking Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, lacunar infarction, off label use on Feb 23, 2010 from DENMARK Additional patient health information: Male patient , weighting 202.8 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Exenatide dosage: 5 Ug, Daily (1/d). During the same period patient was treated with APROVEL (300 Mg, Daily (1/d)) (View Aprovel Review and Aprovel Label ), ACTRAPID /00030501/ (45 Iu, 3/d) (View Actrapid /00030501/ Review and Actrapid /00030501/ Label ), INSULATARD (60 Iu, Daily (1/d)) (View Insulatard Review and Insulatard Label ).

6608417-1 | Blood Glucose Increased, Cardio-respiratory Arrest, Loss Of Consciousness, Mydriasis, Pupillary Reflex Impaired
Adverse event was reported on Feb 23, 2010 by a Female patient taking Exenatide (View Usage) (Dosage: 2.0 Mg, Weekly (1/w)) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 65 years of age, Patient had the following side effects: blood glucose increased, cardio-respiratory arrest, loss of consciousness, mydriasis, pupillary reflex impaired. During the same period patient was treated with GLYCORAN (500 Mg, Daily (1/d)) (View Glycoran Review and Glycoran Label ), ACTOS (15 Mg, Daily (1/d)) (View Actos Review and Actos Label ), XALATAN (Unk, Daily (1/d)) (View Xalatan Review and Xalatan Label ), CARTEOLOL HYDROCHLORIDE (Unk, Daily (1/d)) (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ), HYALURONATE SODIUM (Unk, 4/d) (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ).

6596454-5 | Faeces Discoloured, Melaena
on Feb 15, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: faeces discoloured, melaena. Exenatide dosage: 2 Mg, Weekly (1/w). During the same period patient was treated with GLIMICRON (40 Mg, Daily (1/d)) (View Glimicron Review and Glimicron Label ), MELBIN (750 Mg, Unk) (View Melbin Review and Melbin Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ), LIPITOR (10 Mg, Unk) (View Lipitor Review and Lipitor Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6592891-3 | Cardiac Disorder
on Feb 10, 2010 Male patient from SYRIAN ARAB REPUBLIC , 51 years of age, was diagnosed with diabetes mellitus and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder. Exenatide dosage: 5 Ug, Unk. During the same period patient was treated with LANTUS (Unk, Daily (1/d)) (View Lantus Review and Lantus Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6580861-0 | Cardio-respiratory Arrest
Patient was taking Exenatide (View Usage). Patient had the following side effects: cardio-respiratory arrest on Feb 09, 2010 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with type 2 diabetes mellitus and. Exenatide dosage: 2.0 Mg, Weekly (1/w). During the same period patient was treated with GLYCORAN (500 Mg, Daily (1/d)) (View Glycoran Review and Glycoran Label ), ACTOS (15 Mg, Daily (1/d)) (View Actos Review and Actos Label ), XALATAN (Unk, Daily (1/d)) (View Xalatan Review and Xalatan Label ), CARTEOLOL HYDROCHLORIDE (Unk, Daily (1/d)) (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ), HYALURONATE SODIUM (Unk, 4/d) (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ).

6576419-X |
Adverse event was reported on Feb 05, 2010 by a Female patient taking Exenatide (View Usage) (Dosage: 2.0 Mg, Weekly (1/w)) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 65 years of age, .

6533559-9 | Deafness, Hearing Impaired, Injection Site Extravasation, Injection Site Haematoma
on Jan 04, 2010 Female patient from UNITED STATES , weighting 211.0 lb, was diagnosed with type 2 diabetes mellitus, back pain (What is back pain?) and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: deafness, hearing impaired, injection site extravasation, injection site haematoma. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with GLUCOPHAGE XR (Unk, 2/d) (View Glucophage Xr Review and Glucophage Xr Label ), SYMLIN (10 Ug, 2/d) (View Symlin Review and Symlin Label ), SYNTHROID (50 Ug, Unk) (View Synthroid Review and Synthroid Label ), ZOCOR (20 Mg, Unk) (View Zocor Review and Zocor Label ), MOBIC (15 Mg, As Needed) (View Mobic Review and Mobic Label ), FLEXERIL (10 Mg, As Needed) (View Flexeril Review and Flexeril Label ).

6516516-8 | Altered State Of Consciousness, Asthenia, Palpitations
on Dec 11, 2009 Male patient from UNITED KINGDOM , 57 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). Patient had the following side effects: altered state of consciousness, asthenia, palpitations. Exenatide dosage: 10 Ug, Unk. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (75 Mg, Unk) (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), GLICLAZIDE (80 Mg, Unk) (View Gliclazide Review and Gliclazide Label ), LYRICA (200 Mg, Unk) (View Lyrica Review and Lyrica Label ), METFORMIN HCL (500 Mg, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), MINOCIN (View Minocin Review and Minocin Label ).

6506138-7 | Cerebral Infarction, Myocardial Infarction
Patient was taking Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: cerebral infarction, myocardial infarction on Dec 11, 2009 from SWEDEN Additional patient health information: Male patient , 59 years of age, . Exenatide dosage: 10 Ug, 2/d. During the same period patient was treated with TROMBYL (75 Mg, Unk) (View Trombyl Review and Trombyl Label ). Patient was hospitalized.

6504219-5 | Arthralgia, Dizziness
Adverse event was reported on Dec 04, 2009 by a Female patient taking Exenatide (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: GREECE , 63 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, dizziness (What is dizziness?). During the same period patient was treated with METFORMIN W/ROSIGLITAZONE (4 Mg, Daily (1/d)) (View Metformin W/rosiglitazone Review and Metformin W/rosiglitazone Label ), GLIMEPIRIDE (3 Mg, Daily (1/d)) (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (1700 Mg, Daily (1/d)) (View Metformin Hcl Review and Metformin Hcl Label ).

6474856-5 | Pneumonia
on Jun 10, 2009 Female patient from JAPAN , weighting 156.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension, depression (What is depression?) and was treated with Exenatide (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with AMARYL (1.5 Mg, Daily (1/d)) (View Amaryl Review and Amaryl Label ), METFORMIN HCL (750 Mg, Daily (1/d)) (View Metformin Hcl Review and Metformin Hcl Label ), BLOPRESS (4 Mg, Daily (1/d)) (View Blopress Review and Blopress Label ), AMLODIPINE (2.5 Mg, Daily (1/d)) (View Amlodipine Review and Amlodipine Label ), SOLANAX (0.6 Mg, Daily (1/d)) (View Solanax Review and Solanax Label ), DOGMATYL (150 Mg, Daily (1/d)) (View Dogmatyl Review and Dogmatyl Label ). Patient was hospitalized.

6474600-1 | Non-cardiac Chest Pain
on Feb 12, 2009 Male patient from UNITED STATES , weighting 291.8 lb, was diagnosed with diabetes mellitus, anxiety (What is anxiety?), neuropathy peripheral, coronary artery disease (What is coronary artery disease?), depression (What is depression?), type 2 diabetes mellitus, hypertension and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: non-cardiac chest pain. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6473230-5 | Erosive Oesophagitis
Patient was taking Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: erosive oesophagitis on Aug 05, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 134.0 lb, was diagnosed with headache (What is headache?) and. Exenatide dosage: 10 Ug, Daily (1/d). During the same period patient was treated with EXENATIDE LONG ACTING RELEASE 2MG (8 Mg, Daily (1/d)) (View Exenatide Long Acting Release 2mg Review and Exenatide Long Acting Release 2mg Label ), ALEVE (Unk, Weekly (1/w)) (View Aleve Review and Aleve Label ). Patient was hospitalized.

6471372-1 | Dermatitis Allergic
Adverse event was reported on Feb 27, 2008 by a Female patient taking Exenatide (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, hypertension, cardiac disorder, hypercholesterolaemia and. Location: GERMANY , weighting 204.1 lb, Patient had the following side effects: dermatitis allergic. During the same period patient was treated with METFORMIN HCL (2000 Mg, Other, 2000 Mg, Daily (500 Mg Morning, 500 Mg Afternoon, 1000 Mg Evening)) (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRIDE (4, (0.5 - 0 - 0)) (View Glimepiride Review and Glimepiride Label ), ENALAGAMMA (5, (0 - 0 - 1)) (View Enalagamma Review and Enalagamma Label ), ENALAPRIL HCT (10/25, (1 - 0 - 0)) (View Enalapril Hct Review and Enalapril Hct Label ), METOHEXAL (95, (0.5 - 0 - 0)) (View Metohexal Review and Metohexal Label ), ASPIRIN (100, (0 - 1 - 0)) (View Aspirin Review and Aspirin Label ), SIMVASTATIN (40, (0 - 0 - 1)) (View Simvastatin Review and Simvastatin Label ).

6470900-X | Bladder Cancer Recurrent, Blood Glucose Increased, Injection Site Haemorrhage, Injection Site Pain, White Blood Cell Count Decreased
on Jan 19, 2008 Male patient from UNITED STATES , weighting 210.0 lb, was diagnosed with type 2 diabetes mellitus, bladder disorder, gout (What is gout?), hyperhomocysteinaemia, hypertension, blood cholesterol and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: bladder cancer recurrent, blood glucose increased, injection site haemorrhage, injection site pain, white blood cell count decreased. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with VESICARE /01735902/ (5 Mg, Daily (1/d)) (View Vesicare /01735902/ Review and Vesicare /01735902/ Label ), ALLOPURINOL (300 Mg, Daily (1/d)) (View Allopurinol Review and Allopurinol Label ), FOLTX /01079901/ (Unk, Daily (1/d)) (View Foltx /01079901/ Review and Foltx /01079901/ Label ), METOPROLOL /00376902/ (50 Mg, 2/d) (View Metoprolol /00376902/ Review and Metoprolol /00376902/ Label ), AMLODIPINE (5 Mg, 2/d) (View Amlodipine Review and Amlodipine Label ), CRESTOR /01588602/ (5 Mg, Daily (1/d)) (View Crestor /01588602/ Review and Crestor /01588602/ Label ). Patient was hospitalized.

6470229-X | Pancreatitis Acute
on Nov 28, 2007 Male patient from INDIA , 59 years of age, weighting 189.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with MIXTARD 30/70 ^NOVO NORDISK^ (8 Units In Morning) (View Mixtard 30/70 ^novo Nordisk^ Review and Mixtard 30/70 ^novo Nordisk^ Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ). Patient was hospitalized.

6469239-8 | Blood Glucose Increased, Diabetic Ketoacidosis, Dyspnoea, Pancreatitis, Type 1 Diabetes Mellitus, Weight Decreased
Patient was taking Exenatide (View Usage). Patient had the following side effects: blood glucose increased, diabetic ketoacidosis, dyspnoea, pancreatitis, type 1 diabetes mellitus, weight decreased on Jan 14, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with type 2 diabetes mellitus and. Exenatide dosage: 10 Ug, 2/d. During the same period patient was treated with NOVOLOG (Unk, As Needed) (View Novolog Review and Novolog Label ), LANTUS (Unk, Unk) (View Lantus Review and Lantus Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ZETIA (View Zetia Review and Zetia Label ), CRESTOR (View Crestor Review and Crestor Label ), XENICAL (Unk, As Needed) (View Xenical Review and Xenical Label ).

6469139-3 | Blood Glucose Increased, Decreased Appetite, Injection Site Rash, Pancreatitis, Weight Decreased
Adverse event was reported on Jan 10, 2008 by a Female patient taking Exenatide (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, blood cholesterol increased and. Location: UNITED STATES , weighting 170.0 lb, After Exenatide was administered, patient had the following side effects: blood glucose increased, decreased appetite, injection site rash, pancreatitis, weight decreased. During the same period patient was treated with METFORMIN HCL (1000 Mg, 2/d) (View Metformin Hcl Review and Metformin Hcl Label ), AVANDAMET (Unk, Unk) (View Avandamet Review and Avandamet Label ), LIPITOR (10 Mg, Each Evening) (View Lipitor Review and Lipitor Label ), ZETIA (10 Mg, Each Evening) (View Zetia Review and Zetia Label ), PREMPRO (1.5 Mg, Daily (1/d)) (View Prempro Review and Prempro Label ), ASPIRIN (81 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ).

6468940-X | Anaemia, Pancreatitis Acute
on Mar 21, 2008 Female patient from UNITED STATES , weighting 313.7 lb, was diagnosed with diabetes mellitus and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pancreatitis acute. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with LISINOPRIL (10 Mg, Daily (1/d)) (View Lisinopril Review and Lisinopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACTOS (View Actos Review and Actos Label ), SINGULAIR (View Singulair Review and Singulair Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6449119-4 | Bronchitis
on Nov 11, 2009 Male patient from UNITED STATES , weighting 191.0 lb, was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertension, amnesia and was treated with Exenatide (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?). Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with ZETIA (View Zetia Review and Zetia Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), FLOMAX (View Flomax Review and Flomax Label ), COZAAR (View Cozaar Review and Cozaar Label ), PROSCAR (View Proscar Review and Proscar Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), AMARYL (View Amaryl Review and Amaryl Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6426718-7 | Gastrointestinal Haemorrhage
Patient was taking Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: gastrointestinal haemorrhage on Oct 26, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 47 years of age, was diagnosed with diabetes mellitus and. Exenatide dosage: . Patient was hospitalized.

6426619-4 | Bronchitis, Chronic Obstructive Pulmonary Disease, Hypercapnia, Hypoxia, Respiratory Acidosis
Adverse event was reported on Oct 28, 2009 by a Male patient taking Exenatide (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertension, amnesia and. Location: UNITED STATES , weighting 191.0 lb, Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, hypercapnia, hypoxia, respiratory acidosis. During the same period patient was treated with ZETIA (View Zetia Review and Zetia Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), FLOMAX (View Flomax Review and Flomax Label ), COZAAR (View Cozaar Review and Cozaar Label ), PROSCAR (View Proscar Review and Proscar Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), AMARYL (View Amaryl Review and Amaryl Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6411377-X | Deafness, Hearing Impaired, Injection Site Extravasation, Injection Site Haematoma
on Oct 15, 2009 Female patient from UNITED STATES , weighting 211.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exenatide (View Usage). Patient had the following side effects: deafness, hearing impaired, injection site extravasation, injection site haematoma. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), SYMLIN (10 Ug, 2/d) (View Symlin Review and Symlin Label ).

6391089-1 | Nervous System Disorder, Renal Failure, Unresponsive To Stimuli
on Oct 06, 2009 Male patient from UNITED STATES , 55 years of age, weighting 222.0 lb, was diagnosed with hyperglycaemia and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: nervous system disorder, renal failure, unresponsive to stimuli. Exenatide dosage: 5 Ml/hr Continuous Iv.

6284090-X | Pancreatitis Acute
Patient was taking Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute on Jul 14, 2009 from GERMANY Additional patient health information: Male patient , 64 years of age, was diagnosed with type 2 diabetes mellitus and. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6273964-1 | Nausea
Adverse event was reported on Jul 08, 2009 by a Female patient taking Exenatide (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: KOREA, REPUBLIC OF , weighting 98.99 lb, Patient had the following side effects: nausea (What is nausea?). During the same period patient was treated with METFORMIN HCL (500 Mg, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRIDE (3 Mg, Unk) (View Glimepiride Review and Glimepiride Label ). Patient was hospitalized.

6250791-2 | Biliary Colic
on Jun 19, 2009 Female patient from GREECE , weighting 249.1 lb, was diagnosed with diabetes mellitus and was treated with Exenatide (View Usage). After Exenatide was administered, patient had the following side effects: biliary colic. Exenatide dosage: 5 Ug, 2/d. During the same period patient was treated with GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6241122-2 | Diabetes Mellitus, Nausea
on Jun 12, 2009 Female patient from FRANCE , weighting 185.2 lb, was diagnosed with diabetes mellitus and was treated with Exenatide (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, nausea (What is nausea?). Exenatide dosage: 2x10 Ug, Daily (1/d). During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), STAGID (View Stagid Review and Stagid Label ), PRETERAX (View Preterax Review and Preterax Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

6231645-4 | Cerebrovascular Accident
Patient was taking Exenatide (View Usage). Patient had the following side effects: cerebrovascular accident on Jun 05, 2009 from GERMANY Additional patient health information: Male patient , weighting 291.0 lb, . Exenatide dosage: Unk, Unk. During the same period patient was treated with BENALAPRIL (10 Mg, 2/d) (View Benalapril Review and Benalapril Label ), FUROSEMID (40 Mg, 2/d) (View Furosemid Review and Furosemid Label ), ASPIRIN (100 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), SIMVABETA (40 Mg, Daily (1/d)) (View Simvabeta Review and Simvabeta Label ), BISOPROLOL (5 Mg, 2/d) (View Bisoprolol Review and Bisoprolol Label ), ESIDRIX (Unk, Daily (1/d)) (View Esidrix Review and Esidrix Label ). Patient was hospitalized.